Corporate DisclosureIBP
IBP Corporate Disclosure — 13 April 2021
Announcement summary
- What happened
- IBP published a corporate disclosure on 13 April 2021. Read the full announcement for details.
- Company
- Indo-Bangla Pharmaceuticals Limited
- Announcement published
Original announcement
Referring to their earlier letter no. IBPL/Board secretariat/DSE/news/2021/19 and news disseminated by DSE dated 23.03.2021 regarding suspending the production and marketing of all licensed items of lndo-Bangla Pharmaceuticals Ltd., the Company has informed that the Directorate General of Drug Administration (DGDA) has withdrawn the temporary suspension order of production and marketing of all licensed items by issued memo No. DGDA/ML-032/06/7151 on 12 April 2021.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616ace4e5a6b000040053dd0
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from IBP
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.